195 related articles for article (PubMed ID: 17570849)
1. Interleukin-10 plays an early role in generating virus-specific T cell anergy.
Maris CH; Chappell CP; Jacob J
BMC Immunol; 2007 Jun; 8():8. PubMed ID: 17570849
[TBL] [Abstract][Full Text] [Related]
2. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cells.
Belnoue E; Fontannaz-Bozzotti P; Grillet S; Lambert PH; Siegrist CA
J Virol; 2007 Jul; 81(14):7338-50. PubMed ID: 17494081
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.
Wille A; Gessner A; Lother H; Lehmann-Grube F
Eur J Immunol; 1989 Jul; 19(7):1283-8. PubMed ID: 2503388
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte-mediated antiviral immune responses in mice are diminished by treatment with monoclonal antibody directed against the interleukin-2 receptor.
Utermöhlen O; Tárnok A; Bönig L; Lehmann-Grube F
Eur J Immunol; 1994 Dec; 24(12):3093-9. PubMed ID: 7805738
[TBL] [Abstract][Full Text] [Related]
6. Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent.
Richter K; Perriard G; Oxenius A
Eur J Immunol; 2013 Mar; 43(3):649-54. PubMed ID: 23348876
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo.
Blattman JN; Grayson JM; Wherry EJ; Kaech SM; Smith KA; Ahmed R
Nat Med; 2003 May; 9(5):540-7. PubMed ID: 12692546
[TBL] [Abstract][Full Text] [Related]
8. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.
Keppler SJ; Theil K; Vucikuja S; Aichele P
Eur J Immunol; 2009 Jul; 39(7):1774-83. PubMed ID: 19548244
[TBL] [Abstract][Full Text] [Related]
9. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
[TBL] [Abstract][Full Text] [Related]
10. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
Leist TP; Kohler M; Eppler M; Zinkernagel RM
J Immunol; 1989 Jul; 143(2):628-32. PubMed ID: 2544648
[TBL] [Abstract][Full Text] [Related]
11. Restoring function in exhausted CD8 T cells during chronic viral infection.
Barber DL; Wherry EJ; Masopust D; Zhu B; Allison JP; Sharpe AH; Freeman GJ; Ahmed R
Nature; 2006 Feb; 439(7077):682-7. PubMed ID: 16382236
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression.
Matter MS; Claus C; Ochsenbein AF
Eur J Immunol; 2008 Jul; 38(7):1847-56. PubMed ID: 18506879
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
Mueller K; Schweier O; Pircher H
Eur J Immunol; 2008 Oct; 38(10):2874-85. PubMed ID: 18825743
[TBL] [Abstract][Full Text] [Related]
14. Peripheral clonal deletion of antiviral memory CD8+ T cells.
Moskophidis D; Laine E; Zinkernagel RM
Eur J Immunol; 1993 Dec; 23(12):3306-11. PubMed ID: 8258345
[TBL] [Abstract][Full Text] [Related]
15. Host factors influencing viral persistence.
Thomsen AR; Nansen A; Andreasen SO; Wodarz D; Christensen JP
Philos Trans R Soc Lond B Biol Sci; 2000 Aug; 355(1400):1031-41. PubMed ID: 11186304
[TBL] [Abstract][Full Text] [Related]
16. Resolution of a chronic viral infection after interleukin-10 receptor blockade.
Ejrnaes M; Filippi CM; Martinic MM; Ling EM; Togher LM; Crotty S; von Herrath MG
J Exp Med; 2006 Oct; 203(11):2461-72. PubMed ID: 17030951
[TBL] [Abstract][Full Text] [Related]
17. Role of very late antigen-1 in T-cell-mediated immunity to systemic viral infection.
Kauffmann SØ; Thomsen AR; Christensen JP
Scand J Immunol; 2006 Apr; 63(4):290-8. PubMed ID: 16623929
[TBL] [Abstract][Full Text] [Related]
18. The proteasome inhibitor bortezomib enhances the susceptibility to viral infection.
Basler M; Lauer C; Beck U; Groettrup M
J Immunol; 2009 Nov; 183(10):6145-50. PubMed ID: 19841190
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key.
Bachmann MF; Hunziker L; Zinkernagel RM; Storni T; Kopf M
Eur J Immunol; 2004 Feb; 34(2):317-26. PubMed ID: 14768036
[TBL] [Abstract][Full Text] [Related]
20. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
